Guangzhou Innogen Pharmaceutl Grp Co Ltd
public_traded
Guangzhou Innogen Pharmaceutl Grp Co Ltd is publicly traded on HKSE under ticker 2591.HK.
Guangzhou Innogen Pharmaceutl Grp Co Ltd is a China-based investment holding company focused on the research, development, and commercialization of pharmaceutical products, particularly innovative, humanized, long-acting GLP-1 receptor agonists for diabetes and other metabolic diseases